A comparison of the relative activities of a number of GABAB antagonists in the isolated vas deferens of the rat

Br J Pharmacol. 1991 Mar;102(3):631-4. doi: 10.1111/j.1476-5381.1991.tb12224.x.

Abstract

1. A series of GABAB receptor antagonists were tested against (+/-)-baclofen for activity on the presynaptic GABAB receptor in the rat vas deferens. 2. All the antagonists tested caused a rightward shift in the concentration-response curve to (+/-)-baclofen. 3. pA2 values calculated from full Schild analysis were as follows: phaclofen, pA2 = 4.3; delta-amino valeric acid, pA2 = 4.4; 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP 35348), pA2 = 5.0; 3-amino-propyl(n-hexyl)phosphinic acid (3-APHPA), pA2 = 4.5. 4. These results show that none of the above compounds possess potent antagonist activity at the GABAB receptor (i.e. pA2 > 6) in this peripheral tissue. In addition, the more recently available phosphinic acid antagonists, appear to offer no great advance over the GABAB antagonists previously available.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Baclofen / pharmacology
  • Dose-Response Relationship, Drug
  • GABA-B Receptor Antagonists*
  • In Vitro Techniques
  • Male
  • Organophosphorus Compounds / pharmacology
  • Rats
  • Rats, Wistar
  • Vas Deferens / drug effects*
  • Vas Deferens / physiology

Substances

  • GABA-B Receptor Antagonists
  • Organophosphorus Compounds
  • 3-aminopropyl(hexyl)phosphinic acid
  • CGP 35348
  • Baclofen